We are live on ! Find out more
JAGX icon

Jaguar Health

0 hedge funds and large institutions have $3.94M invested in Jaguar Health in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more call options, than puts

Call options by funds: $197K | Put options by funds: $41K

0% less ownership

Funds ownership: 0%0% (-0%)

17% less capital invested

Capital invested by funds: $4.75M → $3.94M (-$810K)

100% less funds holding

Funds holding: 10 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
$197K
Puts
$41K
Net Calls
+$156K
Net Calls Change
-$50K

JAGX Hedge Fund Activity: Q1 2022 in Review

0 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q1 2022, worth a combined $3.94M — down 17% from $4.75M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of JAGX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $2.39M sold.

  • 0 institutional investors held Jaguar Health (JAGX) as of Q1 2022, down from 1 in Q4 2021.
  • Funds reported $3.94M of Jaguar Health stock for Q1 2022, down 17% quarter-over-quarter.
  • 0 funds opened new Jaguar Health positions in Q1 2022 and 1 closed out, a net change of -1 holder.
  • The largest Jaguar Health seller in Q1 2022 was Vanguard Group, an estimated $2.39M sold.

Based on aggregated 13F filings for Q1 2022.